DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Fioretto P, Del Prato S, Buse JB. et al.
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (CKD Stage 3A): The DERIVE Study).
Diabetes Obes Metab 2018;
DOI: 10.1111/dom.13413.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.